Henry H. Hsu

4.9k total citations · 3 hit papers
52 papers, 2.5k citations indexed

About

Henry H. Hsu is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henry H. Hsu has authored 52 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Hepatology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henry H. Hsu's work include Hepatitis C virus research (10 papers), Musculoskeletal synovial abnormalities and treatments (8 papers) and Hepatitis B Virus Studies (5 papers). Henry H. Hsu is often cited by papers focused on Hepatitis C virus research (10 papers), Musculoskeletal synovial abnormalities and treatments (8 papers) and Hepatitis B Virus Studies (5 papers). Henry H. Hsu collaborates with scholars based in United States, Canada and Japan. Henry H. Hsu's co-authors include Harry B. Greenberg, Jean Dubuisson, David G. Russell, Ramsey Cheung, Charles M. Rice, Teresa L. Wright, Lewis J. Rubin, Victor F. Tapson, David B. Badesch and Srinivas Murali and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Henry H. Hsu

51 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

2006 454 citations Vallerie V. McLaughlin, Ronald J. Oudiz et al. American Journal of Respiratory and Critical Care Medicine profile →
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

2015 433 citations Nicholas Butowski, Howard Colman et al. profile →
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses

1994 354 citations Jean Dubuisson, Henry H. Hsu et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry H. Hsu United States	17	1.1k	1.1k	573	480	368	52	2.5k
Guadalupe Ercilla Spain	28	1.3k 1.2×	1.4k 1.4×	231 0.4×	414 0.9×	49 0.1×	69	2.7k
Frederick A. Nunes United States	15	588 0.5×	546 0.5×	102 0.2×	439 0.9×	122 0.3×	25	2.7k
Massimo Fiorilli Italy	28	584 0.5×	539 0.5×	219 0.4×	1.1k 2.3×	19 0.1×	118	2.5k
Christoph T. Berger Switzerland	23	271 0.3×	111 0.1×	264 0.5×	803 1.7×	93 0.3×	65	1.8k
David Booth Australia	21	1.5k 1.4×	1.8k 1.7×	37 0.1×	658 1.4×	153 0.4×	35	2.9k
Antonio Carúz Spain	23	949 0.9×	1000 1.0×	53 0.1×	803 1.7×	40 0.1×	74	2.7k
Ming Shi China	27	1.5k 1.4×	1.3k 1.2×	182 0.3×	1.8k 3.8×	22 0.1×	91	4.2k
William Stevenson United States	29	497 0.5×	536 0.5×	64 0.1×	347 0.7×	24 0.1×	71	2.6k
G. Spira Israel	21	410 0.4×	276 0.3×	64 0.1×	265 0.6×	52 0.1×	49	1.5k
Christian S. Kuhr United States	25	393 0.4×	107 0.1×	140 0.2×	304 0.6×	96 0.3×	63	2.1k

Countries citing papers authored by Henry H. Hsu

Since Specialization

Citations

This map shows the geographic impact of Henry H. Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry H. Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry H. Hsu more than expected).

Fields of papers citing papers by Henry H. Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry H. Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry H. Hsu. The network helps show where Henry H. Hsu may publish in the future.

Co-authorship network of co-authors of Henry H. Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Henry H. Hsu. A scholar is included among the top collaborators of Henry H. Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry H. Hsu. Henry H. Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Zhe, Hye Kyoung Sung, Leigang Jin, et al.. (2024). The adiponectin‐derived peptide ALY688 protects against the development of metabolic dysfunction‐associated steatohepatitis. Clinical and Translational Science. 17(6). e13760–e13760. 5 indexed citations

Dadson, Keith, Hye Kyoung Sung, Oyeronke Ayansola, et al.. (2024). Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF). Biomedicine & Pharmacotherapy. 171. 116119–116119. 8 indexed citations

Lei, Yubin, et al.. (2024). Development of a non-invasive bioassay for adiponectin target engagement in mice. iScience. 27(10). 110994–110994. 1 indexed citations

Cooke, David L., Henry H. Hsu, Jeanette A. Stewart, et al.. (2022). Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension. Ophthalmology Glaucoma. 6(2). 198–205. 3 indexed citations

Smith, Catherine C., Aaron D. Viny, Evan Massi, et al.. (2021). Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia. Clinical Cancer Research. 27(14). 4003–4011. 11 indexed citations

Crawford, Kathryn, et al.. (2019). Effects of ALY688 on Atropine-Induced Dry Eye in Rabbits. Investigative Ophthalmology & Visual Science. 60(9). 305–305. 1 indexed citations

Li, Ying, Rujun Jin, Lan Li, et al.. (2019). Therapeutic Effect of Topical Adiponectin-Derived Short Peptides Compared with Globular Adiponectin in Experimental Dry Eye and Alkali Burn. Journal of Ocular Pharmacology and Therapeutics. 36(2). 88–96. 8 indexed citations

Gelhorn, Heather L., Grant Maclaine, John H. Healey, et al.. (2015). Patient-reported outcome instruments meaningful and relevant for tenosynovial giant cell tumor (TGCT): A qualitative study.. Journal of Clinical Oncology. 33(15_suppl). 10521–10521. 1 indexed citations

Butowski, Nicholas, Howard Colman, John Frederick De Groot, et al.. (2014). A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 32(15_suppl). 2023–2023. 15 indexed citations

10.

Zhen, Boguang, Tie‐Hua Ng, & Henry H. Hsu. (2011). Multiple-Stage Sampling Procedure for Lot Release with Consideration of Both Manufacturer’s and Consumer’s Risks. Drug Information Journal. 45(4). 469–480. 2 indexed citations

11.

Wirostko, Barbara, Hiroshi Umeno, Henry H. Hsu, & Muralitharan Kengatharan. (2011). Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS907 in Normotensive Cynomolgus Monkeys. 52(14). 3096–3096. 1 indexed citations

12.

Campochiaro, Peter A., Syed Mahmood Shah, Gulnar Hafiz, et al.. (2010). Topical Mecamylamine for Diabetic Macular Edema. American Journal of Ophthalmology. 149(5). 839–851.e1. 22 indexed citations

13.

McLaughlin, Vallerie V., Ronald J. Oudiz, Adaani Frost, et al.. (2006). Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(11). 1257–1263. 454 indexed citations breakdown →

14.

McLaughlin, Vallerie V., Ronald J. Oudiz, Adaani Frost, et al.. (2005). A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ILOPROST INHALATION AS ADD-ON THERAPY TO BOSENTAN IN PULMONARY ARTERIAL HYPERTENSION (PAH). CHEST Journal. 128(4). 160S–160S. 9 indexed citations

15.

Soza, Alejandro, Theo Heller, Marc G. Ghany, et al.. (2005). Pilot study of interferon gamma for chronic hepatitis C. Journal of Hepatology. 43(1). 67–71. 26 indexed citations

16.

Pappas, Peter G., Beatriz Bustamante, Eduardo Ticona, et al.. (2004). Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis. The Journal of Infectious Diseases. 189(12). 2185–2191. 142 indexed citations

17.

Boyce, Thomas G., Henry H. Hsu, Edith C. Sannella, et al.. (2000). Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine. 19(2-3). 217–226. 66 indexed citations

18.

Hsu, Henry H., Sergio Abrignani, & Michael Houghton. (1999). PROSPECTS FOR A HEPATITIS C VIRUS VACCINE. Clinics in Liver Disease. 3(4). 901–915. 10 indexed citations

19.

Dubuisson, Jean, Henry H. Hsu, Ramsey Cheung, et al.. (1994). Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. Journal of Virology. 68(10). 6147–6160. 354 indexed citations breakdown →

20.

Hsu, Henry H., Maritza González, Steven K. H. Foung, Stephen M. Feinstone, & Harry B. Greenberg. (1991). Antibodies to hepatitis C virus in low-risk blood donors: Implications for counseling positive donors. Gastroenterology. 101(6). 1724–1727. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact